Literature DB >> 15138182

Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.

Gang Xin1, Ming-Hui Zhao, Hai-Yan Wang.   

Abstract

The detection rate of antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with clinically suspected small vessel vasculitis was investigated, and their antigen specificity and demographic features were analyzed. A number of sera (n = 5,604) sent to our referral laboratory for ANCA screening were tested by indirect immunofluorescence (IIF), enzyme-linked immunosorbent assays (ELISAs) for myeloperoxidase (MPO)- and proteinase 3 (PR3)-ANCA. Then the IIF-ANCA-positive sera that were negative for MPO- and PR3-ANCA were further tested by antigen-specific ELISA by using other five highly purified known ANCA antigens as solid-phase ligands. The known antigens included bactericidal/permeability-increasing protein (BPI), human leukocyte elastase (HLE), lactoferrin, cathepsin G, and azurocidins. Of the 5,604 sera, 267 (4.76%) sera were IIF-ANCA positive and 390 (7%) were antinuclear antibody (ANA) positive in the IIF assay. Of the IIF-positive samples, 213 were anti-MPO positive, 32 were anti-PR3 positive, and five cases were positive for both. Of the 48 sera positive for IIF-ANCA but negative for MPO- and PR3-ANCA, 13 sera (27%) recognized other target antigens, 7 sera recognized BPI, 5 recognized HLE, 1 recognize cathepsin G, and 1 recognized azurocidin. None of the sera recognized lactoferrin, and one serum sample recognized both BPI and HLE. The majority of ANCA-positive patients presented in summer or winter. There was no difference in gender (male/female ratio, 1:1.12) in ANCA-positive patients with a mean age of 53.1 years. The male/female ratio was 1.17:1 for patients over 60 years of age; however, it was 1:4 for patients under 20 years of age. We conclude that ANCA-related diseases are not rare in China, and the major antigens are MPO and PR3. When the IIF technique is used to detect ANCA, ANA should be carefully distinguished.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138182      PMCID: PMC404588          DOI: 10.1128/CDLI.11.3.559-562.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  20 in total

Review 1.  Classification and epidemiology of the vasculitides.

Authors:  R A Watts; D G Scott
Journal:  Baillieres Clin Rheumatol       Date:  1997-05

Review 2.  The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens.

Authors:  A Wiik; L Stummann; L Kjeldsen; N Borregaard; S Ullman; S Jacobsen; P Halberg
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

3.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

4.  Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

Authors:  R J Falk; S Hogan; T S Carey; J C Jennette
Journal:  Ann Intern Med       Date:  1990-11-01       Impact factor: 25.391

5.  A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract.

Authors:  M H Zhao; C M Lockwood
Journal:  J Immunol Methods       Date:  1996-10-16       Impact factor: 2.303

Review 6.  International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

Authors:  J Savige; D Gillis; E Benson; D Davies; V Esnault; R J Falk; E C Hagen; D Jayne; J C Jennette; B Paspaliaris; W Pollock; C Pusey; C O Savage; R Silvestrini; F van der Woude; J Wieslander; A Wiik
Journal:  Am J Clin Pathol       Date:  1999-04       Impact factor: 2.493

7.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

8.  Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis.

Authors:  M H Zhao; S J Jones; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

9.  Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.

Authors:  P K Li; J C Leung; F M Lai; A Wang; S F Lui; C B Leung; K N Lai
Journal:  Am J Nephrol       Date:  1994       Impact factor: 3.754

10.  Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis.

Authors:  M H Zhao; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

View more
  9 in total

1.  ANCA-associated glomerulonephritis/systemic vasculitis in childhood: clinical features-outcome.

Authors:  Ekaterini Siomou; Despoina Tramma; Claire Bowen; David V Milford
Journal:  Pediatr Nephrol       Date:  2012-05-31       Impact factor: 3.714

2.  The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children.

Authors:  Feng Yu; Jian-Ping Huang; Wan-Zhong Zou; Ming-Hui Zhao
Journal:  Pediatr Nephrol       Date:  2006-02-21       Impact factor: 3.714

Review 3.  Antineutrophil cytoplasmic autoantibody-associated vasculitis in Chinese patients.

Authors:  Peng-Cheng Xu; Min Chen; Ming-Hui Zhao
Journal:  Clin Exp Nephrol       Date:  2012-11-23       Impact factor: 2.801

Review 4.  Epidemiology of systemic vasculitis.

Authors:  Suzanne E Lane; Richard Watts; David G I Scott
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

5.  Clinical [corrected] and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre.

Authors:  M Chen; F Yu; Y Zhang; M H Zhao
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

6.  Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients.

Authors:  Ting Meng; Chanjuan Shen; Rong Tang; Wei Lin; Joshua D Ooi; Peter J Eggenhuizen; Ya-Ou Zhou; Jinbiao Chen; Fang He; Zhou Xiao; Xiang Ao; Weisheng Peng; Wannian Nie; Qiaoling Zhou; Ping Xiao; Yong Zhong; Xiangcheng Xiao
Journal:  Clin Exp Med       Date:  2021-09-22       Impact factor: 5.057

7.  Clinicopathological characteristics and outcomes of Chinese patients with scanty immune deposits lupus nephritis: a large cohort study from a single center.

Authors:  Qiuyu Li; Di Song; Fengmei Wang; Ying Tan; Feng Yu; Minghui Zhao
Journal:  ScientificWorldJournal       Date:  2014-02-04

8.  Epidemiology of Glomerular Disease in Southern Arizona: Review of 10-Year Renal Biopsy Data.

Authors:  Sangeetha Murugapandian; Iyad Mansour; Mohammad Hudeeb; Khaled Hamed; Emad Hammode; Babitha Bijin; Sepehr Daheshpour; Bijin Thajudeen; Pradeep Kadambi
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

9.  Circulating Level of Neutrophil Extracellular Traps Is Not a Useful Biomarker for Assessing Disease Activity in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Huan Wang; Li-Li Sha; Tian-Tian Ma; Lu-Xia Zhang; Min Chen; Ming-Hui Zhao
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.